Barry E. Greene
2013 - Alnylam Pharmaceuticals
In 2013, Barry E. Greene earned a total compensation of $4M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 143% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,750 |
|---|---|
| Option Awards | $3,206,876 |
| Salary | $500,000 |
| Other | $7,746 |
| Total | $3,983,372 |
Greene received $3.2M in option awards, accounting for 81% of the total pay in 2013.
Greene also received $268.8K in non-equity incentive plan, $500K in salary and $7.7K in other compensation.
Rankings
In 2013, Barry E. Greene's compensation ranked 1,771st out of 12,286 executives tracked by ExecPay. In other words, Greene earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,771 out of 12,286 | 86th |
Division Manufacturing | 576 out of 4,612 | 88th |
Major group Chemicals And Allied Products | 152 out of 1,466 | 90th |
Industry group Drugs | 102 out of 1,160 | 91st |
Industry Pharmaceutical Preparations | 89 out of 890 | 90th |
Source: SEC filing on March 17, 2016.
Greene's colleagues
We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2013.
2013
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2013
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2013
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2013
Michael Mason
Alnylam Pharmaceuticals